Annals of the New York Academy of Sciences

Cover image for Vol. 1035 Protective Strategies for Neurodegenerative Diseases

December 2004

Volume 1035 Protective Strategies for Neurodegenerative Diseases

Pages ix–xiii, 1–353

  1. Frontmatter

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
  2. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. Effect of Hypoxia/Ischemia and Hypoxic Preconditioning/Reperfusion on Expression of Some Amyloid-Degrading Enzymes (pages 21–33)

      NATALIA N. NALIVAEVAA, LILIA FISK, EKATERINA G. KOCHKINA, SVETLANA A. PLESNEVA, IGOR A. ZHURAVIN, EVA BABUSIKOVA, DUSAN DOBROTA and ANTHONY J. TURNER

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.002

    2. The Integrated Role of Desferrioxamine and Phenserine Targeted to an Iron-Responsive Element in the APP-mRNA 5′-Untranslated Region (pages 34–48)

      AMANDA VENTI, TONY GIORDANO, PAUL EDER, ASHLEY I. BUSH, DEBOMOY K. LAHIRI, NIGEL H. GREIG and JACK T. ROGERS

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.003

    3. BACE1 Gene Expression and Protein Degradation (pages 49–67)

      WEIHUI ZHOU, HONG QING, YIGANG TONG and WEIHONG SONG

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.004

  3. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models (pages 68–84)

      GREG M. COLE, TAKASHI MORIHARA, GISELLE P. LIM, FUSHENG YANG, AYNUN BEGUM and SALLY A. FRAUTSCHY

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.005

    2. Microglia as a Potential Bridge between the Amyloid β-Peptide and Tau (pages 85–103)

      MASASHI KITAZAWA, TRITIA R. YAMASAKI and FRANK M. LAFERLA

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.006

  4. Protective Strategies for Neurodegenerative Diseases

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. Inflammation and the Degenerative Diseases of Aging (pages 104–116)

      PATRICK L. McGEER and EDITH G. McGEER

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.007

  5. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
  6. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. Neuroprotection from Complement-Mediated Inflammatory Damage (pages 147–164)

      AMOD P. KULKARNI, LAURIE A. KELLAWAY, DEBOMOY K. LAHIRI and GIRISH J. KOTWAL

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.010

    2. Vaccinia Virus Complement Control Protein Reduces Inflammation and Improves Spinal Cord Integrity Following Spinal Cord Injury (pages 165–178)

      DAVID N. REYNOLDS, SCOTT A. SMITH, YI P. ZHANG, QIU MENGSHENG, DEBOMOY K. LAHIRI, DANTE J. MORASSUTTI, CHRISTOPHER B. SHIELDS and GIRISH J. KOTWAL

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.011

  7. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. Melatonin Relieves the Neural Oxidative Burden that Contributes to Dementias (pages 179–196)

      RUSSEL J. REITER, DUN-XIAN TAN and MIGUEL A. PAPPOLLA

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.012

    2. Retardation of Brain Aging by Chronic Treatment with Melatonin (pages 197–215)

      S C BONDY, D K LAHIRI, V M PERREAU, K Z SHARMAN, A CAMPBELL, J ZHOU and E H SHARMAN

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.013

    3. Melatonin, Metals, and Gene Expression: Implications in Aging and Neurodegenerative Disorders (pages 216–230)

      DEBOMOY K. LAHIRI, DEMAO CHEN, PREETI LAHIRI, JACK T. ROGERS, NIGEL H. GREIG and STEPHEN BONDY

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.014

  8. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. The Degeneration of Dopamine Neurons in Parkinson's Disease: Insights from Embryology and Evolution of the Mesostriatocortical System (pages 231–249)

      PHILIPPE VERNIER, FREDERIC MORET, SOPHIE CALLIER, MARINA SNAPYAN, CHRISTOPHE WERSINGER and ANITA SIDHU

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.015

    2. The Role of α-Synuclein in Both Neuroprotection and Neurodegeneration (pages 250–270)

      ANITA SIDHU, CHRISTOPHE WERSINGER, CHARBEL E-H. MOUSSA and PHILIPPE VERNIER

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.016

  9. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation

    1. Top of page
    2. Frontmatter
    3. Protective Strategies for Neurodegenerative Diseases: Part I. Alzheimer's Disease
    4. Protective Strategies for Neurodegenerative Diseases: Part II. Antioxidants and NSAIDs as Neuroprotective Strategies
    5. Protective Strategies for Neurodegenerative Diseases
    6. Protective Strategies for Neurodegenerative Diseases: Part III. Inflammation and Neurodegenerative Diseases
    7. Protective Strategies for Neurodegenerative Diseases: Part IV. Complement and Neurodegenerative Diseases
    8. Protective Strategies for Neurodegenerative Diseases: Part V. Melatonin and Neuroprotection
    9. Protective Strategies for Neurodegenerative Diseases: Part VI. Parkinson's Disease
    10. Protective Strategies for Neurodegenerative Diseases: Part VII. Therapeutic Strategies and Pharmacological Manipulation
    1. New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF-α Inhibitors, and GLP-1 Receptor Agonists (pages 290–315)

      NIGEL H. GREIG, MARK P. MATTSON, TRACYANN PERRY, SIC L. CHAN, TONY GIORDANO, KUMAR SAMBAMURTI, JACK T. ROGERS, HAIM OVADIA and DEBOMOY K. LAHIRI

      Article first published online: 12 JAN 2006 | DOI: 10.1196/annals.1332.018

SEARCH

SEARCH BY CITATION